Related Experiment Videos

[Changes in blood lipoproteins in patients with peripheral atherosclerosis after hemosorption]

Voprosy Meditsinskoi Khimii
|January 1, 1984
PubMed

Insights

Extracorporeal haemosorption temporarily lowers blood lipids in peripheral atherosclerosis patients. Post-treatment, high-density lipoprotein cholesterol levels significantly increase, potentially improving clinical outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Technology

Context:

  • Obliterating peripheric atherosclerosis is characterized by elevated cholesterol and triglycerides.
  • Patients exhibit lower high-density lipoprotein (HDL) cholesterol levels compared to controls.
  • HDL cholesterol inversely correlates with disease severity.

Purpose:

  • To investigate the effects of extracorporeal haemosorption on lipid profiles in peripheral atherosclerosis.
  • To evaluate changes in lipoprotein concentrations, including HDL cholesterol, after treatment.
  • To explore the relationship between observed alterations and clinical outcomes.

Summary:

  • Extracorporeal haemosorption using activated charcoal and heparin reduced cholesterol, triglycerides, and lipoprotein levels in patients.
  • While initial lipid levels returned to baseline, HDL cholesterol significantly increased by 39% within 7-14 days post-treatment.
  • Polyacrylamide gel disc electrophoresis confirmed these HDL alterations.

Impact:

  • The observed increase in HDL cholesterol may contribute to the favorable clinical effects of haemosorption in peripheral atherosclerosis.
  • These findings suggest haemosorption influences lipid metabolism and lipoprotein dynamics.
  • Further research is needed to elucidate the mechanisms behind the sustained HDL increase.

Related Concept Videos